232 related articles for article (PubMed ID: 18803638)
1. Metformin suppresses intestinal polyp growth in ApcMin/+ mice.
Tomimoto A; Endo H; Sugiyama M; Fujisawa T; Hosono K; Takahashi H; Nakajima N; Nagashima Y; Wada K; Nakagama H; Nakajima A
Cancer Sci; 2008 Nov; 99(11):2136-41. PubMed ID: 18803638
[TBL] [Abstract][Full Text] [Related]
2. Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin/+ mice.
Velmurugan B; Singh RP; Kaul N; Agarwal R; Agarwal C
Neoplasia; 2010 Jan; 12(1):95-102. PubMed ID: 20072658
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib malate inhibits intestinal tumor development in male Apc
Chen L; Xu P; Xiao Q; Chen L; Li S; Jian JM; Zhong YB
Int Immunopharmacol; 2021 Jan; 90():107128. PubMed ID: 33191180
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
7. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Niho N; Mutoh M; Takahashi M; Tsutsumi K; Sugimura T; Wakabayashi K
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2970-4. PubMed ID: 15710887
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.
Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV
Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
[TBL] [Abstract][Full Text] [Related]
10. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Heat-Killed Enterococcus faecalis Strain EC-12 on Mouse Intestinal Tumor Development.
Miyamoto S; Komiya M; Fujii G; Hamoya T; Nakanishi R; Fujimoto K; Tamura S; Kurokawa Y; Takahashi M; Ijichi T; Mutoh M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406434
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R
Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518
[TBL] [Abstract][Full Text] [Related]
13. Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial.
Higurashi T; Takahashi H; Endo H; Hosono K; Yamada E; Ohkubo H; Sakai E; Uchiyama T; Hata Y; Fujisawa N; Uchiyama S; Ezuka A; Nagase H; Kessoku T; Matsuhashi N; Yamanaka S; Inayama Y; Morita S; Nakajima A
BMC Cancer; 2012 Mar; 12():118. PubMed ID: 22443173
[TBL] [Abstract][Full Text] [Related]
14. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice.
Oshima M; Takahashi M; Oshima H; Tsutsumi M; Yazawa K; Sugimura T; Nishimura S; Wakabayashi K; Taketo MM
Carcinogenesis; 1995 Nov; 16(11):2605-7. PubMed ID: 7586174
[TBL] [Abstract][Full Text] [Related]
15. Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil.
Fujimoto K; Fujii G; Mutoh M; Yasunaga M; Tanaka H; Wada M
Eur J Cancer Prev; 2013 Jan; 22(1):8-10. PubMed ID: 22504657
[TBL] [Abstract][Full Text] [Related]
16. Period 2 mutation accelerates ApcMin/+ tumorigenesis.
Wood PA; Yang X; Taber A; Oh EY; Ansell C; Ayers SE; Al-Assaad Z; Carnevale K; Berger FG; Peña MM; Hrushesky WJ
Mol Cancer Res; 2008 Nov; 6(11):1786-93. PubMed ID: 19010825
[TBL] [Abstract][Full Text] [Related]
17. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.
Lee SH; Hu LL; Gonzalez-Navajas J; Seo GS; Shen C; Brick J; Herdman S; Varki N; Corr M; Lee J; Raz E
Nat Med; 2010 Jun; 16(6):665-70. PubMed ID: 20473309
[TBL] [Abstract][Full Text] [Related]
18. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.
Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M
Carcinogenesis; 2003 Jul; 24(7):1219-24. PubMed ID: 12807720
[TBL] [Abstract][Full Text] [Related]
19. The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc
Ono J; Shime H; Takaki H; Takashima K; Funami K; Yoshida S; Takeda Y; Matsumoto M; Kasahara M; Seya T
J Biomed Sci; 2017 Oct; 24(1):79. PubMed ID: 29041928
[TBL] [Abstract][Full Text] [Related]
20. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
